Business
Response to CMA review into veterinary market
Response to CMA review into veterinary market.
About this update from Cvs Group Plc
[{"type":"text","content":"\n\n7 September 2023\n \nCVS Group plc\n(\"CVS\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\n \n \nResponse to CMA review into the veterinary services market\n \nCVS, the UK quoted veterinary group and a leading provider of integrated veterinary services, notes that the Competition and Markets Authority (\"CMA\") has launched a review into the UK veterinary services market for household pets. We always work closely with our regulators and we and our colleagues will support the CMA review. \n \nOur purpose at CVS is to give the best possible care to animals and we continually invest in our colleagues, practices and clinical equipment to enhance the care to our clients and their patients. The Group has always sought to ensure its prices are appropriate and reflect fair value to our clients. Our pricing structures are set by clinicians to ensure these align with our purpose. \n \nAs the CMA have recognised, there continues to be a significant shortage of vets in the UK and employment costs represent the most significant proportion of our cost base. Our pricing reflects this and other inflationary pressures experienced in recent years.\n \nWe have a clear strategy to continue to expand our network and to improve clinical care through investment in facilities, equipment, technology and our people.\n \nWe will announce our full year results on 21 September 2023.\n \n \n \nCVS Group plc via Camarco\nRichard Fairman, CEO\nBen Jacklin, Deputy CEO\nRobin Alfonso, CFO\n \nPeel Hunt LLP (Nominated Adviser & Broker) &nb...